Department of Medicine, University of California - San Francisco, San Francisco, CA.
Liver Transplant Program, Intermountain Medical Center, Murray, UT.
Hepatology. 2018 Sep;68(3):1101-1110. doi: 10.1002/hep.29906. Epub 2018 May 20.
In liver transplantation, adults with small stature have a greater susceptibility to waitlist mortality. This may explain the persistent waitlist mortality disparity that exists for women. We hypothesized that women who receive early offers of pediatric donor livers have improved waitlist survival, and that preferentially offering these organs to women mitigates this sex-based disparity. We analyzed donor liver offers from 2010 to 2014. Adult candidates who received a first offer that ranked within the first three match run positions from the donors' perspective were classified based on gender and whether they received a pediatric versus adult offer. We used competing risks regression to associate first offer type and waitlist mortality. A total of 8,101 waitlist candidates received a first offer that was ranked within the first three match run positions: 5.6% (293/5,202) men and 6.2% (179/2,899) women received a pediatric donor liver as their first offer. In multivariable analyses, compared with adult-first men, adult-first women (subhazard ratio [sHR] 1.33, 95% confidence interval 1.17-1.51, P < 0.01) had an increased pretransplant mortality risk while pediatric-first men and pediatric-first women had noninferior risks of morality. Pediatric-to-adult and adult-to-adult recipients had similar risks of graft failure and posttransplant mortality.
Our study examines allograft selection by donor age, recipient sex, and in effect size as a means to address disparities in waitlist mortality. We found that women who received a pediatric donor liver as the first offer had a lower risk of waitlist mortality compared with those who receive adult offers. Our data provides a simple approach to mitigating the increased waitlist mortality experienced by women by incorporating donor and recipient size as variables into organ allocation. (Hepatology 2018).
在肝移植中,身材矮小的成年人更易发生等待名单死亡。这可能解释了女性持续存在的等待名单死亡率差异。我们假设,接受小儿供体肝脏早期报价的女性具有更好的等待名单生存机会,并且优先向女性提供这些器官可以减轻这种基于性别的差异。
我们分析了 2010 年至 2014 年的供体肝脏报价。根据性别以及他们是否收到小儿供体或成人供体的报价,将从供体角度排名前三个匹配运行位置内的首次报价的成人候选者进行分类。我们使用竞争风险回归来关联首次报价类型和等待名单死亡率。共有 8101 名等待名单候选者收到了排名前三个匹配运行位置内的首次报价:5.6%(293/5202)的男性和 6.2%(179/2899)的女性作为他们的首次报价收到了小儿供体肝脏。
在多变量分析中,与成人首次男性相比,成人首次女性(亚危险比[ sHR ]1.33,95%置信区间 1.17-1.51,P <0.01)具有更高的移植前死亡率风险,而小儿首次男性和小儿首次女性的死亡率风险无差异。小儿至成人和成人至成人受者的移植物失败和移植后死亡率风险相似。
我们的研究通过检查供体年龄、受者性别以及大小效应对同种异体移植物选择的影响,来解决等待名单死亡率的差异。我们发现,与接受成人供体报价的女性相比,接受小儿供体肝脏作为首次报价的女性等待名单死亡率较低。我们的数据提供了一种简单的方法,可以通过将供体和受体大小作为变量纳入器官分配来减轻女性经历的增加的等待名单死亡率。